Latest Period
Q4 2025
Security Snapshot
Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PCSA) Institutional Ownership
CUSIP: 74275C403
13F Institutional Holders and Ownership History for Q4 2025
Institutions Reporting
10
Shares (Excl. Options)
115,174
Price
$2.88
Save this security research path
Keep this CUSIP in your research flow, then return after the next filing cycle to check what changed.
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- PCSA on Nasdaq
- Shares outstanding
- 2,351,108
- Price per share
- $2.88
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 115,174
- Total reported value
- $330,990
- % of total 13F portfolios
- 0%
- Share change
- +115,174
- Value change
- +$330,990
- Number of holders
- 10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PCSA - Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 74275C403.
- 10 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Latest quarter on this page is Q4 2025.
- Additional quarter-over-quarter change detail appears as history expands.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 74275C403?
CUSIP 74275C403 identifies PCSA - Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74275C403:
Significant Owners of Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PCSA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Chiliz Group Ltd. | 13% | $959,722 | 305,644 | HX Entertainment Ltd | 13 Feb 2026 | |||
| INTRACOASTAL CAPITAL, LLC | 8.1% | $644,000 | 200,000 | Mitchell P. Kopin | 31 Dec 2025 |
As of 31 Dec 2025, 10 institutional investors reported holding 115,174 shares of Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PCSA). This represents 4.9% of the company’s total 2,351,108 outstanding shares.
Institutional Holders of Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PCSA) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 115,174 | $330,990 | +$330,990 | $2.88 | 10 |